Friday , November 22 2019
Home / FT Alphaville / GMO: on the comeback trail

GMO: on the comeback trail

Gallons of ink has been spilled on the question of when value-investing -- the practice of buying treasure priced like trash -- will begin to outperform the market after a torrid decade of returns. To add to the literature is Grantham Mayo van Otterloo’s (GMO) Ben Inker, Head of Asset Allocation at the storied investment firm, who addressed the potential for a reversal in its third quarter letter, released Thursday.In short, the current market reminds him of 2000 -- when the Nasdaq bubble peaked, and EM debt was ebbing near its lowest points -- and that’s reason for some cautious optimism. Well, for its portfolios at least.From the quarterly letter:Ever since 2000, we have always assumed that neither the pain from the 1990s, nor the opportunity set that the pain created, would come our way

FT Alphaville considers the following as important:

This could be interesting, too:

Scott Sumner writes Two views of the Phillips Curve

Scott Sumner writes Don’t boycott artists

[email protected] (Unknown) writes Which organizational forms can best adapt to change?

[email protected] (Luke Froeb) writes Incentives matter: physicians perform fewer surgeries on smokers

Gallons of ink has been spilled on the question of when value-investing -- the practice of...

FT Alphaville
FT Alphaville is a free daily news and commentary service giving finance professionals the information they need, when they need it. In a world where market professionals are inundated with information there is a pressing need to edit and filter, and hopefully sow a few ideas along the way. That’s where the FT Alphaville team comes in.

Leave a Reply

Your email address will not be published. Required fields are marked *